Call Us Contact Us
+44 1494 818 000     Online Enquiry
Lines open
Monday to Thursday
08:30 to 18:00
Friday
08:30 to 17:30
Pharmaceutical | Medical Devices | Scientific | Consumer Healthcare | Dental | Animal Health | FMCG | Executive
         
Latest Jobs
Exclusive vacancies may not be shown here, please contact on +44 or for more information.
Have you registered?
Once you register you can see additional job details, save jobs, track your applications and manage e-lert preferences.

Register now
Testimonials
I have recently completed a maternity cover contract with Zenopa for Leo Pharma. My main contact with Zenopa was with the Contract Manager and I would like to highlight her expert support and friendli...
Eleanor, 2011

Molnlycke expands production of Barrier drapes

30 May 2012 15:43 in Medical Company Product News


Molnlycke has expanded production capabilities for its Barrier drapes with the introduction of a new production line at its manufacturing site in Waremme, Belgium.

The drapes manufactured using the new facilities will offer the same high quality as previous versions of the product, but will be created in a more environmentally-friendly manner, thanks to the design of the machinery.

According to Molnlycke, the new production line delivers 33 percent less energy consumption and a 35 percent reduction in CO2 emissions, while also greatly reducing water usage.

Meanwhile, the large-scale nature of the new facilities will help the company to develop and deliver better and more innovative products in future.

"The new manufacturing line enables us to further improve production quality and to secure production capacity. This will shorten our supply chain," said a statement from the company.

Last month, the firm announced the appointment of Clare Hollingsworth and Fred Colen as the newest members of the Molnlycke board of directors.ADNFCR-8000103-ID-801375228-ADNFCR

Other news stories from 30/05/2012

Related news

Read more in the Zenopa News Archive

How this news is generated

Story collated for Zenopa by the Adfero News Agency



   
© Copyright 2013 Zenopa Ltd